Miller D A, Lucarotti R L, Vlasses P H, Krigstein D J, McKercher P L
Drug Intell Clin Pharm. 1980 Mar;14(3):182-6. doi: 10.1177/106002808001400304.
In an attempt to determine if pharmacists could make significant contributions to SNF patient care in the area of disease management, the drug therapy of the residents of two SNFs was reviewed once monthly for six months by two clinical pharmacist consultants. Pharmacist-identified problems and recommendations were communicated in writing to the medical staff by means of a communication form attached to the patient's chart. Nearly 72 percent of the recommendations made were accepted by the SNF physicians. Descriptions of the cases and corresponding recommendations were distributed to review-panel physicians. These physicians were asked to agree or disagree with the pharmacists' suggestions, and to rate the clinical significance of each recommendation using a modified Likert scale. The clinical pharmacist-consultants were perceived to have had a significant input into disease management in SNF patients.
为了确定药剂师是否能在疾病管理领域为熟练护理机构（SNF）的患者护理做出重大贡献，两名临床药剂师顾问对两家SNF的居民的药物治疗进行了为期六个月的每月一次审查。药剂师发现的问题和建议通过附在患者病历上的沟通表格以书面形式传达给医务人员。提出的建议中近72%被SNF医生接受。病例描述和相应建议分发给审查小组医生。要求这些医生对药剂师的建议表示同意或不同意，并使用改良的李克特量表对每条建议的临床意义进行评分。临床药剂师顾问被认为对SNF患者的疾病管理有重大贡献。
